Hematopoietic stem cells improve dopaminergic neuron in the MPTP-mice

Frontiers in Bioscience

Volumn 18, Issue 3, 2013, Pages 970-981

  Lu, Jingwei ^a   Kanji, Suman ^a   Aggarwal, Reeva ^a   Das, Manjusri ^a   Joseph, Matthew ^a   Wu, Lai Chu ^b   Mao, Hai Quan ^c   Pompili, Vincent J ^d   Hadjiconstantinou, Maria ^a   Das, Hiranmoy ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d OHIO STATE UNIVERSITY   (United States)

Author keywords

Neuron; Parkinson's disease; Regeneration; Umbilical cord. stem cells

Indexed keywords

EID: 84880526930     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/4156     Document Type: Article

References (46)

1. M. Hadjiconstantinou and N. H. Neff: Enhancing aromatic L-amino acid decarboxylase activity: implications for L-DOPA treatment in Parkinson's disease. CNS Neurosci Ther, 14(4), 340-51 (2008).
2. S. Perez-Lloret and O. Rascol: Dopamine receptor agonists for the treatment of early or advanced Parkinson's disease. CNS Drugs, 24(11), 941-68 (2010).
3. G. Fabbrini, J. M. Brotchie, F. Grandas, M. Nomoto and C. G. Goetz: Levodopa-induced dyskinesias. Mov Disord, 22(10), 1379-89; quiz 1523 (2007). (Pubitemid 47280623)
4. G. Pezzoli and M. Zini: Levodopa in Parkinson's disease: from the past to the future. Expert Opin Pharmacother, 11(4), 627-35 (2010).
5. L. Aron and R. Klein: Repairing the parkinsonian brain with neurotrophic factors. Trends Neurosci, 34(2), 88-100 (2011).
6. A. K. Meyer, M. Maisel, A. Hermann, K. Stirl and A. Storch: Restorative approaches in Parkinson's Disease: Which cell type wins the race? Journal of the Neurological Sciences, 289(1-2), 93-103 (2010).
7. A. Bjorklund, S. B. Dunnett, P. Brundin, A. J. Stoessl, C. R. Freed, R. E. Breeze, M. Levivier, M. Peschanski, L. Studer and R. Barker: Neural transplantation for the treatment of Parkinson's disease. Lancet Neurol, 2(7), 437-45 (2003). (Pubitemid 36793939)
8. O. Lindvall: Clinical application of neuronal grafts in Parkinson's disease. J Neurol, 242(1 Suppl 1), S 54-6 (1994).
9. C. Winkler, D. Kirik, A. Bjorklund and S. B. Dunnett: Transplantation in the rat model of Parkinson's disease: ectopic versus homotopic graft placement. Prog Brain Res, 127, 233-65 (2000). (Pubitemid 35469064)
10. P. Brundin, R. A. Barker and M. Parmar: Neural grafting in Parkinson's disease Problems and possibilities. Prog Brain Res, 184, 265-94 (2010).
11. O. Lindvall and Z. Kokaia: Prospects of stem cell therapy for replacing dopamine neurons in Parkinson's disease. Trends in Pharmacological Sciences, 30(5), 260-7 (2009).
12. Y. S. Levy, M. Stroomza, E. Melamed and D. Offen: Embryonic and adult stem cells as a source for cell therapy in Parkinson's disease. Journal of Molecular Neuroscience, 24(3), 353-385 (2004). (Pubitemid 41389375)
13. D. T. Harris: Cord blood stem cells: A review of potential neurological applications. Stem Cell Rev, 4(4), 269-74 (2008).
14. Y. S. Fu, Y. C. Cheng, M. Y. Lin, H. Cheng, P. M. Chu, S. C. Chou, Y. H. Shih, M. H. Ko and M. S. Sung: Conversion of human umbilicacord mesenchymal stem cells in Wharton's jelly to dopaminergic neurons in vitro: potential therapeutic application for Parkinsonism. Stem Cells, 24(1), 115-24 (2006).
15. H. Das, N. Abdulhameed, M. Joseph, R. Sakthivel, H. Q. Mao and V. J. Pompili: Ex vivo nanofiber expansion and genetic modification of human cord blood-derived progenitor/stem cells enhances vasculogenesis. Cell Transplant, 18(3), 305-18 (2009).
16. J. Lu, R. Aggarwal, V. J. Pompili and H. Das: A novel technology for hematopoietic stem cell expansion using combination of nanofiber and growth factors. Recent Pat Nanotechnol, 4(2), 125-35 (2010).
17. R. Aggarwal, J. Lu, S. Kanji, M. Joseph, M. Das, G. J. Noble, B. K. McMichael, S. Agarwal, R. T. Hart, Z. Sun, B. S. Lee, T. J. Rosol, R. Jackson, H.-Q. Mao, V. J. Pompili and H. Das: Human Umbilical Cord Blood- Derived CD34+ Cells Reverse Osteoporosis in NOD/SCID Mice by Altering Osteoblastic and Osteoclastic Activities. PLoS One, 7(6), e39365 (2012).
18. H. Das, J. C. George, M. Joseph, M. Das, N. Abdulhameed, A. Blitz, M. Khan, R. Sakthivel, H. Q. Mao, B. D. Hoit, P. Kuppusamy and V. J. Pompili: Stem cell therapy with overexpressed VEGF and PDGF genes improves cardiac function in a rat infarct model. PLoS One, 4(10), e7325 (2009).
19. K. N. Chua, C. Chai, P. C. Lee, Y. N. Tang, S. Ramakrishna, K. W. Leong and H. Q. Mao: Surfaceaminated electrospun nanofibers enhance adhesion and expansion of human umbilical cord blood hematopoietic stem/progenitor cells. Biomaterials, 27(36), 6043-51 (2006). (Pubitemid 44414973)
20. V. Jackson-Lewis and S. Przedborski: Protocol for the MPTP mouse model of Parkinson's disease. Nat Protoc, 2(1), 141-51 (2007). (Pubitemid 47044700)
21. X. L. Wang, M. Rosol, S. D. Ge, D. Peterson, G. McNamara, H. Pollack, D. B. Kohn, M. D. Nelson and G. M. Crooks: Dynamic tracking of human hematopoietic stem cell engraftment using in vivo bioluminescence imaging. Blood, 102(10), 3478-3482 (2003). (Pubitemid 37409362)
22. M. Hadjiconstantinou, A. P. Mariani and N. H. Neff: GM1 ganglioside-induced recovery of nigrostriatal dopaminergic neurons after MPTP: an immunohistochemical study. Brain Res, 484(1-2), 297-303 (1989). (Pubitemid 19100091)
23. V. M. Goettl, T. A. Wemlinger, A. M. Duchemin, N. H. Neff and M. Hadjiconstantinou: GM1 ganglioside restores dopaminergic neurochemical and morphological markers in aged rats. Neuroscience, 92(3), 991-1000 (1999). (Pubitemid 29287544)
24. M. A. Eglitis and E. Mezey: Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice. Proceedings of the National Academy of Sciences of the United States of America, 94(8), 4080-4085 (1997). (Pubitemid 27180502)
25. C. H. Zhao, Z. D. Ling, M. B. Newman, A. Bhatia and P. M. Carvey: TNF-alpha knockout and minocycline treatment attenuates blood-brain barrier leakage in MPTP-treated mice. Neurobiology of Disease, 26(1), 36-46 (2007). (Pubitemid 46437443)
26. X. Chen, X. Lan, I. Roche, R. Liu and J. D. Geiger: Caffeine protects against MPTP-induced blood-brain barrier dysfunction in mouse striatum. J Neurochem, 107(4), 1147-57 (2008).
27. M. Hadjiconstantinou and N. H. Neff: Differential recovery of dopamine synthetic enzymes following MPTP and the consequences of GM1 ganglioside treatment. Eur J Pharmacol, 181(1-2), 137-9 (1990). (Pubitemid 20197324)
28. D. T. Stephenson, M. A. Childs, Q. Li, S. Carvajal- Gonzalez, A. Opsahl, M. Tengowski, M. D. Meglasson, K. Merchant and M. E. Emborg: Differential loss of presynaptic dopaminergic markers in Parkinsonian monkeys. Cell Transplant, 16(3), 229-44 (2007). (Pubitemid 47300229)
29. J. F. Reinhard Jr., D. B. Miller and J. P. O'Callaghan: The neurotoxicant MPTP (1-methyl-4-phenyl-1, 2, 3, 6- tetrahydropyridine) increases glial fibrillary acidic protein and decreases dopamine levels of the mouse striatum: evidence for glial response to injury. Neurosci Lett, 95(1-3), 246-51 (1988).
30. Y. K. Jang, J. J. Park, M. C. Lee, B. H. Yoon, Y. S. Yang, S. E. Yang and S. U. Kim: Retinoic acid-mediated induction of neurons and glial cells from human umbilical cord-derived hematopoietic stem cells. J Neurosci Res, 75(4), 573-84 (2004). (Pubitemid 38160718)
31. M. Hadjiconstantinou, P. Panula, Z. Lackovic and N. H. Neff: Spinal cord serotonin: A biochemical and immunohistochemical study following transection. Brain Res, 322(2), 245-54 (1984). (Pubitemid 15209379)
32. P. Turowski, P. Adamson and J. Greenwood: Pharmacological targeting of ICAM-1 signaling in brain endothelial cells: potential for treating neuroinflammation. Cell Mol Neurobiol, 25(1), 153-70 (2005). (Pubitemid 40558588)
33. G. Banisadr, D. Skrzydelski, P. Kitabgi, W. Rostene and S. M. Parsadaniantz: Highly regionalized distribution of stromal cell-derived factor-1/CXCL12 in adult rat brain: constitutive expression in cholinergic, dopaminergic and vasopressinergic neurons. European Journal of Neuroscience, 18(6), 1593-1606 (2003). (Pubitemid 37215112)
34. T. N. Tham, F. Lazarini, I. A. Franceschini, F. Lachapelle, A. Amara and M. Dubois-Dalcq: Developmental pattern of expression of the alpha chemokine stromal cell-derived factor 1 in the rat central nervous system. Eur J Neurosci, 13(5), 845-56 (2001). (Pubitemid 32226137)
35. Y. Vagima, K. Lapid, O. Kollet, P. Goichberg, R. Alon and T. Lapidot: Pathways implicated in stem cell migration: The SDF-1/CXCR4 axis. Natural Killer Cell Protocols, 750, 277-89 (2011).
36. C. V. Borlongan, M. Hadman, C. D. Sanberg and P. R. Sanberg: Central nervous system entry of peripherally injected umbilical cord blood cells is not required for neuroprotection in stroke. Stroke, 35(10), 2385-2389 (2004). (Pubitemid 39311268)
37. M. B. Newman, A. E. Willing, J. J. Manresa, C. D. Sanberg and P. R. Sanberg: Cytokines produced by cultured human umbilical cord blood (HUCB) cells: implications for brain repair. Exp Neurol, 199(1), 201-8 (2006).
38. C. J. Barnum and M. G. Tansey: Modeling neuroinflammatory pathogenesis of Parkinson's disease. Prog Brain Res, 184, 113-32 (2010).
39. P. L. McGeer and E. G. McGeer: Glial reactions in Parkinson's disease. Mov Disord, 23(4), 474-83 (2008).
40. J. D. Adams Jr., P. W. Kalivas and C. A. Miller: The acute histopathology of MPTP in the mouse CNS. Brain Res Bull, 23(1-2), 1-17 (1989). (Pubitemid 19259607)
41. Y. X. Chao, B. P. He and S. S. Tay: Mesenchymal stem cell transplantation attenuates blood brain barrier damage and neuroinflammation and protects dopaminergic neurons against MPTP toxicity in the substantia nigra in a model of Parkinson's disease. J Neuroimmunol, 216(1-2), 39-50 (2009).
42. M. Al-Jarrah, M. Jamous, K. Al Zailaey and S. O. Bweir: Endurance exercise training promotes angiogenesis in the brain of chronic/progressive mouse model of Parkinson's Disease. NeuroRehabilitation, 26(4), 369-73 (2010).
43. E. Guatteo, S. Marinelli, R. Geracitano, A. Tozzi, M. Federici, G. Bernardi and N. B. Mercuri: Dopaminecontaining neurons are silenced by energy deprivation: A defensive response or beginning of cell death? Neurotoxicology, 26(5), 857-68 (2005). (Pubitemid 41427526)
44. M. Hadjiconstantinou, A. J. Yates and N. H. Neff: Hypoxia-induced neurotransmitter deficits in neonatal rats are partially corrected by exogenous GM1 ganglioside. J Neurochem, 55(3), 864-9 (1990).
45. E. A. Winkler, R. D. Bell and B. V. Zlokovic: Central nervous system pericytes in health and disease. Nat Neurosci, 14(11), 1398-405 (2011).
46. M. A. Font, A. Arboix and J. Krupinski: Angiogenesis, neurogenesis and neuroplasticity in ischemic stroke. Curr Cardiol Rev, 6(3), 238-44 (2010).